---
figid: PMC4413635__oncotarget-06-3033-g001
figlink: /pmc/articles/PMC4413635/figure/F1/
number: F1
caption: By interacting with CDKs, cyclins form complexes (cyclin D with CDK4/6 and
  cyclin E with CDK2) that phosphorylate Rb1 (phosphorylated Rb1 is inactive). The
  Rb protein is a tumor suppressor that plays a pivotal role in the negative control
  of the cell cycle; Rb1 loss of function is frequently observed in cancer []. When
  Rb1 is phosphorylated, E2F is released and can transcriptionally activate its target
  genes, enabling the G1/S transition of cell cycle. Cyclin D1 (CCND1) can also be
  regulated at the transcription level by the RAS-MEK-ERK pathway and at the translation
  level by mTOR via S6K and 4EBP1 [, , , ]. mTOR inhibitors may attenuate CCND1 action
  by decreasing translation of CCND1. CDK4/6 inhibitors may attenuate the effects
  of this pathway as well, especially in the presence of CDK4/6 amplification or CDKN2A/B
  loss (since CDKN2A/B inhibits CDK4/6 activity). Patients with Rb1 loss or mutations
  would be expected to be resistant to agents such as mTOR or CDK4/6 inhibitors that
  act more proximally.
pmcid: PMC4413635
papertitle: 'Cyclin alterations in diverse cancers: outcome and co-amplification network.'
reftext: Maria Schwaederl√©, et al. Oncotarget. 2015 Feb;6(5):3033-3042.
pmc_ranked_result_index: '26859'
pathway_score: 0.929435
filename: oncotarget-06-3033-g001.jpg
figtitle: 'Cyclin alterations in diverse cancers: outcome and co-amplification network'
year: '2015'
organisms:
- Homo sapiens
ndex: 691b9f8e-debb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4413635__oncotarget-06-3033-g001.html
  '@type': Dataset
  description: By interacting with CDKs, cyclins form complexes (cyclin D with CDK4/6
    and cyclin E with CDK2) that phosphorylate Rb1 (phosphorylated Rb1 is inactive).
    The Rb protein is a tumor suppressor that plays a pivotal role in the negative
    control of the cell cycle; Rb1 loss of function is frequently observed in cancer
    []. When Rb1 is phosphorylated, E2F is released and can transcriptionally activate
    its target genes, enabling the G1/S transition of cell cycle. Cyclin D1 (CCND1)
    can also be regulated at the transcription level by the RAS-MEK-ERK pathway and
    at the translation level by mTOR via S6K and 4EBP1 [, , , ]. mTOR inhibitors may
    attenuate CCND1 action by decreasing translation of CCND1. CDK4/6 inhibitors may
    attenuate the effects of this pathway as well, especially in the presence of CDK4/6
    amplification or CDKN2A/B loss (since CDKN2A/B inhibits CDK4/6 activity). Patients
    with Rb1 loss or mutations would be expected to be resistant to agents such as
    mTOR or CDK4/6 inhibitors that act more proximally.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDK6
  - E2F3
  - CDK4
  - PIK3CG
  - PIK3R3
  - CCNE2
  - CDK2
  - CCNE1
  - PIK3R6
  - HRAS
  - CCND3
  - PIK3CD
  - AKT3
  - AKT1
  - E2F2
  - E2F4
  - CDKN2A
  - CCND1
  - CCND2
  - ERBB2
  - MTOR
  - E2F7
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - E2F5
  - E2F1
  - RB1
  - E2F8
  - CDKN2B
  - EIF4EBP1
  - E2F6
  - PIK3CB
  - NRAS
  - KRAS
  - AKT2
  - Cancer
  - Lung cancer
genes:
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: CyclinE
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE2
  entrez: '9134'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: CyclinE
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE1
  entrez: '898'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: CDKN2A/B
  symbol: CDKN2A
  source: hgnc_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: ERBB2
  symbol: ERBB2
  source: hgnc_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: Rb1
  symbol: RB1
  source: hgnc_symbol
  hgnc_symbol: RB1
  entrez: '5925'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: CDKN2A/B
  symbol: CDKN2B
  source: hgnc_symbol
  hgnc_symbol: CDKN2B
  entrez: '1030'
- word: 4EBP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC4413635__F1
redirect_from: /figures/PMC4413635__F1
figtype: Figure
---
